Ontario’s Minister of Research, Innovation and Science, today announced the launch of 5 cross-disciplinary, multi-institutional Translational Research Initiatives (TRIs), each focused on a single type of, or treatment approach to cancer.
Dr. Steven Gallinger, Toronto Faculty and Head of HPB at UHN, leads the TRI pancreas cancer initiative, called PanCuRx, which was selected as one of the 5 TRIs.
Read more on today’s announcement here: https://news.oicr.on.ca/2017/05/oicr-launches-five-large-scale-ontario-research-initiatives-to-combat-some-of-the-most-deadly-cancers/